ASTRAZENECA PLC-SPONS ADR (AZN) Forecast, Price Target & Analyst Ratings
NYSE:AZN • US0463531089
194.22 USD
-3.3 (-1.67%)
At close: Mar 6, 2026
193.7 USD
-0.52 (-0.27%)
After Hours: 3/6/2026, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ASTRAZENECA PLC-SPONS ADR (AZN).
Forecast Snapshot
Consensus Price Target
$208.02
+ 7.11% Upside
Next Earnings Forecast
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$2.65
Revenue Estimate15.229B
ChartMill Buy Consensus
82.94%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$208.02
Upside
+ 7.11%
From current price of $194.22 to mean target of $208.02, Based on 34 analyst forecasts
Low
$89.20
Median
$217.98
High
$287.50
Price Target Revisions
1 Month
112.72%
3 Months
123.49%
Price Target Summary
34 analysts have analysed AZN and the average price target is 208.03 USD. This implies a price increase of 7.11% is expected in the next year compared to the current price of 194.22.
The average price target has been revised upward by 123.49% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.94%
AZN was analyzed by 34 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AZN.
In the previous month the buy percentage consensus was at a similar level.
AZN was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-02-13 | UBS | Upgrade | Neutral -> Buy |
| 2024-11-20 | UBS | Upgrade | Sell -> Neutral |
| 2024-09-11 | Erste Group | Upgrade | Hold -> Buy |
| 2024-08-12 | TD Cowen | Maintains | Buy -> Buy |
| 2024-05-30 | Argus Research | Maintains | Buy -> Buy |
| 2024-05-30 | Goldman Sachs | Initiate | Buy |
| 2024-04-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-16 | Deutsche Bank | Upgrade | Sell -> Hold |
| 2024-02-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-02-08 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2024-01-23 | Morgan Stanley | Initiate | Overweight |
| 2024-01-03 | Jefferies | Downgrade | Buy -> Hold |
| 2023-09-25 | Jefferies | Upgrade | Hold -> Buy |
| 2023-09-08 | Erste Group | Downgrade | Buy -> Hold |
| 2023-08-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-05-26 | Argus Research | Maintains | Buy -> Buy |
| 2023-04-13 | Argus Research | Maintains | Buy |
| 2023-01-05 | BMO Capital | Initiate | Outperform |
| 2022-11-14 | SVB Leerink | Maintains | Outperform |
| 2022-11-11 | SVB Leerink | Maintains | Outperform |
| 2022-08-29 | Argus Research | Upgrade | Hold -> Buy |
| 2022-05-04 | SVB Leerink | Maintains | Outperform |
| 2022-02-24 | SVB Leerink | Maintains | Outperform |
| 2022-02-11 | DZ Bank | Upgrade | Sell -> Hold |
| 2021-12-07 | Jefferies | Downgrade | Buy -> Hold |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$2.65
Revenue Estimate15.229B
Revenue Q2Q12.08%
EPS Q2Q5.62%
Number of Analysts9
Next Earnings Revisions
Revenue (1 Month)
0.30%
Revenue (3 Months)
0.31%
EPS (1 Month)
97.77%
EPS (3 Months)
97.37%
Next Earnings Summary
AZN is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 2.65 USD and the consensus revenue estimate is 15.23B USD.
The next earnings revenue estimate has been revised upward by 0.31% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 45.811B 3.29% | 54.073B 18.03% | 58.739B 8.63% | 64.689B 10.13% | 68.705B 6.21% | 72.786B 5.94% | 77.219B 6.09% | 81.993B 6.18% | 84.978B 3.64% | 83.885B -1.29% | 83.02B -1.03% | |
| EBITDA YoY % growth | 14.303B -0.03% | 19.371B 35.43% | 19.753B 1.97% | 23.581B 19.38% | 26.062B 10.52% | 28.198B 8.20% | 30.384B 7.75% | 30.732B 1.15% | 32.569B 5.98% | 32.98B 1.26% | 31.614B -4.14% | |
| EBIT YoY % growth | 8.916B 1.00% | 12.683B 42.25% | 14.02B 10.54% | 20.847B 48.69% | 23.101B 10.81% | 25.035B 8.37% | 29.467B 17.70% | 31.995B 8.58% | 34.023B 6.34% | 33.888B -0.40% | 34.498B 1.80% | |
| Operating Margin | 19.46% | 23.46% | 23.87% | 32.23% | 33.62% | 34.40% | 38.16% | 39.02% | 40.04% | 40.40% | 41.55% | |
| EPS YoY % growth | 7.31 8.86% | 8.28 13.24% | 9.24 11.57% | 10.67 15.50% | 12.00 12.50% | 13.18 9.81% | 14.44 9.55% | 15.81 9.49% | 17.07 8.00% | 16.89 -1.07% | 14.93 -11.58% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.65 5.62% | 2.58 18.10% | 2.74 14.05% | 2.05 -4.31% | 2.95 11.23% | 2.83 9.72% | 3.04 11.18% | 2.60 26.94% |
| Revenue Q2Q % growth | 15.229B 12.08% | 15.763B 9.03% | 16.293B 7.25% | 16.653B 7.42% | 15.507B 1.83% | 16.15B 2.46% | 16.928B 3.90% | 17.304B 3.91% |
| EBITDA Q2Q % growth | 7.703B 51.57% | 7.506B 21.85% | 8.318B 5.25% | 5.46B -37.85% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 5.226B 37.60% | 5.144B 47.52% | 5.495B 49.28% | 5.19B 70.05% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
12.90%
EPS Next 5 Year
12.40%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
6.30%
Revenue Next 5 Year
6.77%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
14.61%
EBIT Next 5 Year
11.70%
ASTRAZENECA PLC-SPONS ADR / AZN Forecast FAQ
Can you provide the average price target for ASTRAZENECA PLC-SPONS ADR stock?
34 analysts have analysed AZN and the average price target is 208.03 USD. This implies a price increase of 7.11% is expected in the next year compared to the current price of 194.22.
What is the next earnings date for AZN stock?
ASTRAZENECA PLC-SPONS ADR (AZN) will report earnings on 2026-04-29.
What are the consensus estimates for ASTRAZENECA PLC-SPONS ADR (AZN) next earnings?
The consensus EPS estimate for the next earnings of ASTRAZENECA PLC-SPONS ADR (AZN) is 2.65 USD and the consensus revenue estimate is 15.23B USD.
What is the number of analysts for AZN stock?
The number of analysts covering ASTRAZENECA PLC-SPONS ADR (AZN) is 34.